We are live on ! Find out more
LOGC

LogicBio Therapeutics, Inc. Common Stock
LOGC

Delisted

LOGC was delisted on the 15th of November, 2022.

Back to rankings

43 hedge funds and large institutions have $55.2M invested in LogicBio Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

2% less funds holding

Funds holding: 44 → 43 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

36% less capital invested

Capital invested by funds: $86M → $55.2M (-$30.8M)

Holders
43
Holders Change
-1
Holders Change %
-2.27%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
11
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$3.06M
2
SC
Samlyn Capital
New York
+$455K
3
Northern Trust
Northern Trust
Illinois
+$120K
4
BCM
Bridgeway Capital Management
Texas
+$107K
5
IWM
IHT Wealth Management
Illinois
+$90.7K

Top Sellers

Rank Fund Capital Flow
1
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
-$5.3M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.58M
3
SCM
Sio Capital Management
New York
-$906K
4
Morgan Stanley
Morgan Stanley
New York
-$309K
5
OAM
Oxford Asset Management
United Kingdom
-$136K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$31.9M – – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$4.52M -$2.58M -331,199 -27%
SC
3
Samlyn Capital
New York
$3.94M +$455K +58,520 +8%
Franklin Resources
4
Franklin Resources
California
$3.46M – – –
LPC
5
Lion Point Capital
New York
$2.47M – – –
BlackRock
6
BlackRock
New York
$2.46M -$55.5K -7,131 -1%
JP Morgan Chase
7
JP Morgan Chase
New York
$2.01M +$3.06M +393,304 +2,691%
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.57M +$3.23K +416 +0.1%
State Street
9
State Street
Massachusetts
$629K -$1.62K -208 -0.2%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$506K +$59K +7,590 +8%
Northern Trust
11
Northern Trust
Illinois
$499K +$120K +15,375 +18%
FT
12
Fiduciary Trust
Massachusetts
$188K +$54.4K +6,998 +23%
Goldman Sachs
13
Goldman Sachs
New York
$129K +$6.98K +898 +4%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$103K – – –
N
15
Nuveen
North Carolina
$92K – – –
Charles Schwab
16
Charles Schwab
California
$90K – – –
BCM
17
Bridgeway Capital Management
Texas
$68K +$107K +13,700 New
California State Teachers Retirement System (CalSTRS)
18
California State Teachers Retirement System (CalSTRS)
California
$64K +$1.15K +148 +1%
First Trust Advisors
19
First Trust Advisors
Illinois
$59K -$18K -2,319 -16%
Victory Capital Management
20
Victory Capital Management
Texas
$58K +$67.2K +8,638 +288%
IWM
21
IHT Wealth Management
Illinois
$58K +$90.7K +11,660 New
RhumbLine Advisers
22
RhumbLine Advisers
Massachusetts
$50K – – –
Wells Fargo
23
Wells Fargo
California
$47K -$2.91K -374 -4%
New York State Common Retirement Fund
24
New York State Common Retirement Fund
New York
$29K – – –
UBS Group
25
UBS Group
Switzerland
$24K -$42.7K -5,486 -53%
1
2

LOGC Hedge Fund Activity: Q1 2020 in Review

43 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in LogicBio Therapeutics, Inc. Common Stock (LOGC) for Q1 2020, worth a combined $55.2M — down 36% from $86M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of LOGC and 6 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 11 added.

The largest buyer was JP Morgan Chase, adding an estimated $3.06M. The largest seller was Board of Trustees of The Leland Stanford Junior University, exiting entirely with an estimated $5.3M sold.

  • 43 institutional investors held LogicBio Therapeutics, Inc. Common Stock (LOGC) as of Q1 2020, down from 44 in Q4 2019.
  • Funds reported $55.2M of LogicBio Therapeutics, Inc. Common Stock stock for Q1 2020, down 36% quarter-over-quarter.
  • 6 funds opened new LogicBio Therapeutics, Inc. Common Stock positions in Q1 2020 and 7 closed out, a net change of -1 holder.
  • The largest LogicBio Therapeutics, Inc. Common Stock buyer in Q1 2020 was JP Morgan Chase, an estimated $3.06M added.
  • The largest LogicBio Therapeutics, Inc. Common Stock seller in Q1 2020 was Board of Trustees of The Leland Stanford Junior University, an estimated $5.3M sold.

Based on aggregated 13F filings for Q1 2020.